Therapeutics: BPI fold containing family A member 1 (BPIFA1; LUNX)

In vitro, mouse and patient sample studies suggest anti-BPIFA1 antibodies could help treat NSCLC. In patient samples, BPIFA1 levels were higher in primary NSCLC tumors and metastases than in other can...